-.x-progress-wrap {\r
- border-color:#18181a;\r
-}\r
-\r
-.x-progress-inner {\r
- background-color:#232d38;\r
- background-image:none;\r
-}\r
-\r
-.x-progress-bar {\r
- background-color:#f39a00;\r
- background-image:url(../images/access/progress/progress-bg.gif);\r
- border-top-color:#a66900;\r
- border-bottom-color:#a66900;\r
- border-right-color:#ffb941;\r
-}\r
-\r
-.x-progress-text {\r
- font-size:14px;\r
- font-weight:bold;\r
- color:#fff;\r
-}\r
-\r
-.x-progress-text-back {\r
- color:#aaa;\r
- line-height: 11px;\r
-}\r
+.x-progress-wrap {
+ border-color:#18181a;
+}
+
+.x-progress-inner {
+ background-color:#232d38;
+ background-image:none;
+}
+
+.x-progress-bar {
+ background-color:#f39a00;
+ background-image:url(../images/access/progress/progress-bg.gif);
+ border-top-color:#a66900;
+ border-bottom-color:#a66900;
+ border-right-color:#ffb941;
+ height: 20px !important; /* structural override for Accessibility Theme */
+}
+
+.x-progress-text {
+ font-size:14px;
+ font-weight:bold;
+ color:#fff;
+ padding: 0 5px !important; /* structural override for Accessibility Theme */
+}
+
+.x-progress-text-back {
+ color:#aaa;
+ line-height: 19px;
+}